Company · CIK 0000939767 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
EXELIXIS, INC. · EXEL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2017 SForm 4 → | Mar 7, 7:56 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | $22.72 | $4,544,000 | 60,000 | −76.9% | plan? |
| Mar 3, 2017 MForm 4 → | Mar 7, 7:56 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | $9.91 | $1,982,000 | 160,000 | — | plan? |
| Mar 3, 2017 SForm 4 → | Mar 7, 7:45 pm EST | Patrick J. HaleySr. Vice President, Commercial | 2,500 | $23.04 | $57,600 | 107,193 | −2.28% | plan? |
| Mar 3, 2017 SForm 4 → | Mar 3, 8:20 pm EST | Christopher J. SennerEVP and CFO | 11,000 | $22.80 | $250,800 | 100,398 | −9.87% | plan? |
| Mar 1, 2017 SForm 4 → | Mar 3, 8:18 pm EST | Peter LambEVP, Scientific Strategy & CSO | 45,000 | $22.19 | $998,550 | 73,600 | −37.9% | plan? |
| Mar 1, 2017 MForm 4 → | Mar 3, 8:18 pm EST | Peter LambEVP, Scientific Strategy & CSO | 45,000 | $7.36 | $331,350 | 118,600 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 3, 8:17 pm EST | George PosteDirector | 76,250 | $22.53 | $1,718,185 | 77,555 | −49.6% | plan? |
| Mar 1, 2017 MForm 4 → | Mar 3, 8:17 pm EST | George PosteDirector | 76,250 | $5.20 | $396,850 | 144,955 | — | plan? |
| Feb 1, 2017 SForm 4 → | Feb 3, 7:55 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $18.65 | $1,305,500 | 73,600 | −48.7% | plan? |
| Feb 1, 2017 MForm 4 → | Feb 3, 7:55 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $6.92 | $484,300 | 143,600 | — | plan? |
| Jan 3, 2017 SForm 4 → | Jan 5, 8:25 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $14.65 | $1,025,636 | 73,600 | −48.7% | plan? |
| Jan 3, 2017 MForm 4 → | Jan 5, 8:25 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $5.74 | $401,800 | 143,600 | — | plan? |
| Dec 20, 2016 GForm 5 → | Feb 3, 2017, 7:56 pm EST | Michael MorrisseyPresident and CEO, Director | 2,000 | — | — | 172,698 | — | plan? |
| Dec 16, 2016 SForm 4 → | Dec 16, 7:29 pm EST | Carl B FeldbaumDirector | 25,000 | $17.03 | $425,750 | 48,721 | −33.9% | plan? |
| Dec 16, 2016 MForm 4 → | Dec 16, 7:29 pm EST | Carl B FeldbaumDirector | 25,000 | $10.41 | $260,250 | 73,721 | — | plan? |
| Dec 9, 2016 SForm 4 → | Dec 9, 8:02 pm EST | Alan M GarberDirector | 7,832 | $16.90 | $132,361 | 61,329 | −11.3% | plan? |
| Dec 9, 2016 MForm 4 → | Dec 9, 8:02 pm EST | Alan M GarberDirector | 10,000 | $10.53 | $105,300 | 69,161 | — | plan? |
| Dec 5, 2016 SForm 4 → | Dec 7, 7:03 pm EST | George A ScangosDirector | 204,894 | $17.81 | $3,649,178 | 1,463,648 | −12.3% | plan? |
| Dec 5, 2016 MForm 4 → | Dec 7, 7:03 pm EST | George A ScangosDirector | 358,332 | $8.99 | $3,221,405 | 1,463,824 | — | plan? |
| Dec 1, 2016 SForm 4 → | Dec 2, 7:14 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $16.66 | $1,166,200 | 73,600 | −48.7% | plan? |
| Dec 1, 2016 MForm 4 → | Dec 2, 7:14 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $5.27 | $368,800 | 143,600 | — | plan? |
| Dec 1, 2016 SForm 4 → | Dec 2, 7:13 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | $16.73 | $368,060 | 158,053 | −12.2% | plan? |
| Dec 1, 2016 MForm 4 → | Dec 2, 7:13 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | $8.99 | $197,780 | 180,053 | — | plan? |
| Nov 9, 2016 SForm 4 → | Nov 14, 7:37 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | $15.00 | $3,000,000 | 60,000 | −76.9% | plan? late |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:37 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | $8.99 | $1,798,000 | 260,000 | — | plan? late |
| Nov 9, 2016 SForm 4 → | Nov 14, 7:36 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | $15.00 | $330,000 | 158,053 | −12.2% | plan? late |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:36 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | $8.99 | $197,780 | 180,053 | — | plan? late |
| Nov 9, 2016 SForm 4 → | Nov 14, 7:34 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $13.15 | $920,500 | 73,600 | −48.7% | plan? late |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:34 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | $5.17 | $362,000 | 143,600 | — | plan? late |
| Sep 26, 2016 AForm 4 → | Sep 26, 7:38 pm EDT | Michael MorrisseyPresident and CEO, Director | 60,000 | — | — | 60,000 | — | plan? |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:43 pm EDT | Jeffrey HessekielEVP and General Counsel | 16,250 | — | — | 246,617 | — | plan? |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:42 pm EDT | Peter LambEVP, Scientific Strategy & CSO | 16,250 | — | — | 73,600 | — | plan? |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:41 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 20,000 | — | — | 156,441 | — | plan? |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:39 pm EDT | Christopher J. SennerEVP and CFO | 20,000 | — | — | 152,727 | — | plan? |
| Sep 22, 2016 AForm 4 → | Sep 26, 5:31 pm EDT | Julie SmithDirector | 763 | — | — | 763 | — | plan? |
| Aug 31, 2016 SForm 4 → | Sep 2, 4:34 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 131,155 | $10.98 | $1,440,082 | 136,441 | −49.0% | plan? |
| Aug 31, 2016 MForm 4 → | Sep 2, 4:34 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 132,662 | $9.73 | $1,290,801 | 267,596 | — | plan? |
| Aug 4, 2016 SForm 4 → | Aug 5, 7:29 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 42,338 | $11.00 | $465,718 | 132,016 | −24.3% | plan? |
| Aug 4, 2016 MForm 4 → | Aug 5, 7:29 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 42,338 | $9.73 | $411,949 | 174,354 | — | plan? |
| Jul 15, 2016 AFForm 4/A → | Nov 23, 4:16 pm EST | Christopher J. SennerEVP and CFO | 66,751 | $8.44 | $394,578 | 125,976 | — | plan? |
| Jun 1, 2016 MForm 4 → | Jun 2, 6:37 pm EDT | Jeffrey HessekielEVP and General Counsel | 200,000 | $1.70 | $340,000 | 230,367 | — | plan? |
| May 9, 2016 PForm 4 → | May 11, 5:23 pm EDT | Lance WillseyDirector | 60,000 | $4.97 | $297,900 | 568,273 | +11.8% | plan? |
| Feb 11, 2016 AFForm 4 → | Feb 16, 8:52 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 90,730 | $4.20 | $105,974 | 132,016 | — | plan? |
| Feb 11, 2016 AFForm 4 → | Feb 16, 8:51 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,832 | $4.20 | $106,907 | 57,350 | — | plan? |
| Feb 11, 2016 AFForm 4 → | Feb 16, 8:50 pm EST | Jeffrey HessekielEVP and General Counsel | 69,437 | $4.20 | $82,047 | 30,367 | — | plan? |
| Feb 11, 2016 AFForm 4 → | Feb 16, 8:49 pm EST | Christopher J. SennerEVP and CFO | 74,417 | $4.20 | $87,549 | 132,727 | — | plan? |
| Feb 11, 2016 AFForm 4 → | Feb 16, 8:48 pm EST | Michael MorrisseyPresident and CEO, Director | 157,435 | $4.20 | $181,226 | 71,137 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:55 pm EST | Stelios PapadopoulosDirector | 15,071 | — | — | 1,228,471 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:55 pm EST | George PosteDirector | 13,830 | — | — | 77,555 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:54 pm EST | Alan M GarberDirector | 10,550 | — | — | 59,161 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:52 pm EST | George A ScangosDirector | 6,383 | — | — | 1,310,210 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:52 pm EST | Lance WillseyDirector | 13,298 | — | — | 508,273 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:50 pm EST | Carl B FeldbaumDirector | 8,688 | — | — | 48,721 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:49 pm EST | Charles CohenDirector | 13,830 | — | — | 248,180 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:47 pm EST | Jack L WyszomierskiDirector | 12,146 | — | — | 68,110 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:46 pm EST | Vincent T MarchesiDirector | 13,387 | — | — | 120,070 | — | plan? |
| Dec 10, 2015 PForm 4 → | Dec 11, 7:43 pm EST | Lance WillseyDirector | 100,000 | $4.89 | $488,550 | 494,975 | +25.3% | plan? |
| Nov 16, 2015 FMForm 4 → | Nov 17, 4:23 pm EST | Peter LambEVP, Discovery Research & CSO | 3,213 | — | — | 37,426 | — | plan? |
| Nov 16, 2015 FMForm 4 → | Nov 17, 4:23 pm EST | Gisela SchwabEVP and Chief Medical Officer | 4,299 | — | — | 91,750 | — | plan? |
| Oct 16, 2015 SForm 4 → | Oct 19, 5:08 pm EDT | Peter LambEVP, Discovery Research & CSO | 51,549 | $5.80 | $298,984 | 36,473 | −58.6% | plan? |
| Oct 16, 2015 MForm 4 → | Oct 19, 5:08 pm EDT | Peter LambEVP, Discovery Research & CSO | 51,549 | $5.63 | $290,221 | 88,022 | — | plan? |
| Oct 12, 2015 SForm 4 → | Oct 14, 5:05 pm EDT | Peter LambEVP, Discovery Research & CSO | 300,876 | $5.84 | $1,756,792 | 36,473 | −89.2% | plan? |
| Oct 12, 2015 MForm 4 → | Oct 14, 5:05 pm EDT | Peter LambEVP, Discovery Research & CSO | 300,876 | $5.63 | $1,693,932 | 37,073 | — | plan? |
| Jul 15, 2015 AForm 4 → | Jul 17, 7:28 pm EDT | Christopher J. SennerEVP and CFO | 100,000 | — | — | 100,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2017 MForm 4 → | Apr 4, 8:00 pm EDT | Vincent T MarchesiDirector | 10,000 | — | — | 0 | — | |
| Mar 31, 2017 MForm 4 → | Mar 31, 6:35 pm EDT | Jack L WyszomierskiDirector | 10,000 | — | — | 0 | — | |
| Mar 27, 2017 MForm 4 → | Mar 28, 8:15 pm EDT | Charles CohenDirector | 10,000 | — | — | 0 | — | |
| Mar 22, 2017 MForm 4 → | Mar 24, 7:41 pm EDT | Jeffrey HessekielEVP and General Counsel | 55,000 | — | — | 145,000 | — | |
| Mar 20, 2017 MForm 4 → | Mar 21, 7:29 pm EDT | Carl B FeldbaumDirector | 10,000 | — | — | 0 | — | |
| Mar 20, 2017 MForm 4 → | Mar 21, 7:28 pm EDT | Stelios PapadopoulosDirector | 10,000 | — | — | 0 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 7:52 pm EDT | Lance WillseyDirector | 10,000 | — | — | 0 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 7:51 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 50,007 | — | — | 177,700 | — | |
| Mar 10, 2017 MForm 4 → | Mar 10, 7:37 pm EST | Vincent T MarchesiDirector | 40,000 | — | — | 0 | — | |
| Mar 3, 2017 MForm 4 → | Mar 7, 8:00 pm EST | Jeffrey HessekielEVP and General Counsel | 100,000 | — | — | 130,000 | — | |
| Mar 3, 2017 MForm 4 → | Mar 7, 7:56 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | — | — | 0 | — | |
| Mar 1, 2017 MForm 4 → | Mar 3, 8:18 pm EST | Peter LambEVP, Scientific Strategy & CSO | 45,000 | — | — | 0 | — | |
| Mar 1, 2017 MForm 4 → | Mar 3, 8:17 pm EST | George PosteDirector | 76,250 | — | — | 0 | — | |
| Feb 23, 2017 AForm 4 → | Feb 24, 9:00 pm EST | Julie SmithDirector | 16,620 | — | — | 16,620 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 7:55 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | — | — | 20,000 | — | |
| Jan 3, 2017 MForm 4 → | Jan 5, 8:25 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | — | — | 15,000 | — | |
| Dec 19, 2016 AForm 4 → | Dec 21, 8:42 pm EST | Patrick J. HaleySr. Vice President, Commercial | 50,000 | — | — | 50,000 | — | |
| Dec 16, 2016 MForm 4 → | Dec 16, 7:29 pm EST | Carl B FeldbaumDirector | 25,000 | — | — | 0 | — | |
| Dec 9, 2016 MForm 4 → | Dec 9, 8:02 pm EST | Alan M GarberDirector | 10,000 | — | — | 0 | — | |
| Dec 5, 2016 MForm 4 → | Dec 7, 7:03 pm EST | George A ScangosDirector | 358,332 | — | — | 0 | — | |
| Dec 1, 2016 MForm 4 → | Dec 2, 7:14 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | — | — | 10,000 | — | |
| Dec 1, 2016 MForm 4 → | Dec 2, 7:13 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | — | — | 0 | — | |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:37 pm EST | Michael MorrisseyPresident and CEO, Director | 200,000 | — | — | 0 | — | late |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:36 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 22,000 | — | — | 22,000 | — | late |
| Nov 9, 2016 MForm 4 → | Nov 14, 7:34 pm EST | Peter LambEVP, Scientific Strategy & CSO | 70,000 | — | — | 55,000 | — | late |
| Sep 26, 2016 AForm 4 → | Sep 26, 7:38 pm EDT | Michael MorrisseyPresident and CEO, Director | 360,000 | — | — | 360,000 | — | |
| Sep 22, 2016 AForm 4/A → | Nov 23, 4:16 pm EST | Christopher J. SennerEVP and CFO | 120,000 | — | — | 120,000 | — | |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:43 pm EDT | Jeffrey HessekielEVP and General Counsel | 97,500 | — | — | 97,500 | — | |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:42 pm EDT | Peter LambEVP, Scientific Strategy & CSO | 97,500 | — | — | 97,500 | — | |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:41 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 120,000 | — | — | 120,000 | — | |
| Sep 22, 2016 AForm 4 → | Sep 26, 7:39 pm EDT | Christopher J. SennerEVP and CFO | 120,000 | — | — | 120,000 | — | |
| Sep 22, 2016 AForm 4 → | Sep 26, 5:31 pm EDT | Julie SmithDirector | 26,000 | — | — | 26,000 | — | |
| Aug 31, 2016 MForm 4 → | Sep 2, 4:34 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 132,662 | — | — | 0 | — | |
| Aug 4, 2016 MForm 4 → | Aug 5, 7:29 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 42,338 | — | — | 132,662 | — | |
| Jun 1, 2016 MForm 4 → | Jun 2, 6:37 pm EDT | Jeffrey HessekielEVP and General Counsel | 200,000 | — | — | 200,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:20 pm EDT | George A ScangosDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:18 pm EDT | Vincent T MarchesiDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:16 pm EDT | Carl B FeldbaumDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:15 pm EDT | Stelios PapadopoulosDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:14 pm EDT | Alan M GarberDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:12 pm EDT | Charles CohenDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:10 pm EDT | George PosteDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:08 pm EDT | Jack L WyszomierskiDirector | 40,000 | — | — | 40,000 | — | |
| May 26, 2016 AForm 4 → | May 26, 8:06 pm EDT | Lance WillseyDirector | 40,000 | — | — | 40,000 | — | |
| Apr 28, 2016 AForm 4 → | Apr 29, 7:28 pm EDT | Michael MorrisseyPresident and CEO, Director | 393,750 | — | — | 112,500 | — | |
| Apr 28, 2016 AForm 4 → | Apr 29, 7:26 pm EDT | Gisela SchwabPres Prod Dev & Med Aff & CMO | 187,500 | — | — | 62,500 | — | |
| Apr 28, 2016 AForm 4 → | Apr 29, 7:25 pm EDT | Peter LambEVP, Scientific Strategy & CSO | 143,750 | — | — | 43,750 | — | |
| Apr 28, 2016 AForm 4 → | Apr 29, 7:23 pm EDT | Jeffrey HessekielEVP and General Counsel | 150,000 | — | — | 50,000 | — | |
| Mar 7, 2016 AForm 4 → | Mar 8, 7:17 pm EST | Michael MorrisseyPresident and CEO, Director | 393,750 | — | — | 112,500 | — | |
| Mar 7, 2016 AForm 4 → | Mar 8, 7:16 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 187,500 | — | — | 62,500 | — | |
| Mar 7, 2016 AForm 4 → | Mar 8, 7:15 pm EST | Peter LambEVP, Scientific Strategy & CSO | 143,750 | — | — | 43,750 | — | |
| Mar 7, 2016 AForm 4 → | Mar 8, 7:14 pm EST | Jeffrey HessekielEVP and General Counsel | 150,000 | — | — | 50,000 | — | |
| Feb 11, 2016 AForm 4 → | Feb 16, 8:52 pm EST | Gisela SchwabPres Prod Dev & Med Aff & CMO | 75,000 | — | — | 75,000 | — | |
| Feb 11, 2016 AForm 4 → | Feb 16, 8:51 pm EST | Peter LambEVP, Scientific Strategy & CSO | 40,000 | — | — | 40,000 | — | |
| Feb 11, 2016 AForm 4 → | Feb 16, 8:48 pm EST | Michael MorrisseyPresident and CEO, Director | 150,000 | — | — | 150,000 | — | |
| Nov 16, 2015 MForm 4 → | Nov 17, 4:23 pm EST | Peter LambEVP, Discovery Research & CSO | 2,083 | — | — | 0 | — | |
| Nov 16, 2015 MForm 4 → | Nov 17, 4:23 pm EST | Gisela SchwabEVP and Chief Medical Officer | 3,125 | — | — | 0 | — | |
| Oct 16, 2015 MForm 4 → | Oct 19, 5:08 pm EDT | Peter LambEVP, Discovery Research & CSO | 51,549 | — | — | 0 | — | |
| Oct 12, 2015 MForm 4 → | Oct 14, 5:05 pm EDT | Peter LambEVP, Discovery Research & CSO | 300,876 | — | — | 51,549 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 5:03 pm EDT | Michael MorrisseyPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 5:03 pm EDT | Gisela SchwabEVP and Chief Medical Officer | 245,000 | — | — | 245,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 5:03 pm EDT | Christopher J. SennerEVP and CFO | 225,000 | — | — | 225,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 5:02 pm EDT | Jeffrey HessekielEVP and General Counsel | 190,000 | — | — | 190,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 5:02 pm EDT | Peter LambEVP, Discovery Research & CSO | 190,000 | — | — | 190,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 8:52 pm EDT | Michael MorrisseyPresident and CEO, Director | 1,027,500 | — | — | 225,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 8:50 pm EDT | Gisela SchwabEVP and Chief Medical Officer | 455,000 | — | — | 125,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 8:48 pm EDT | Peter LambEVP, Discovery Research & CSO | 329,500 | — | — | 87,500 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 8:44 pm EDT | Jeffrey HessekielEVP and General Counsel | 300,000 | $1.77 | $530,000 | 100,000 | — | |
| Jul 15, 2015 AForm 4 → | Jul 17, 7:28 pm EDT | Christopher J. SennerEVP and CFO | 350,000 | — | — | 350,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:44 pm EDT | Carl B FeldbaumDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:44 pm EDT | Charles CohenDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:44 pm EDT | Alan M GarberDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:44 pm EDT | George PosteDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:43 pm EDT | Vincent T MarchesiDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:43 pm EDT | Jack L WyszomierskiDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:43 pm EDT | Stelios PapadopoulosDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:43 pm EDT | Lance WillseyDirector | 40,000 | — | — | 40,000 | — | |
| May 28, 2015 AForm 4 → | May 28, 6:42 pm EDT | George A ScangosDirector | 40,000 | — | — | 40,000 | — |